The DFG-funded Research Training Group (RTG) 3095 Protective and pathogenic antibody responses at barrier organs is a collaborative doctoral programme jointly organized by the University of Lübeck and Kiel University two modern and research-intensive universities with strong profiles in medicine molecular biology and life sciences. Their study programmes have consistently achieved top rankings in the CHE Ranking the most comprehensive evaluation of study programmes at German universities.
Immunological barrier organs such as the skin intestine and lungs are continuously exposed to commensal microorganisms pathogens and environmental allergens. As a result infections as well as allergic and autoinflammatory disorders at these mucosal interfaces are frequent and represent a significant burden to public health. Antibody-mediated immune responses play a central role in maintaining homeostasis at these sites: they contribute to the control of pathogen invasion the regulation of gut microbiota and the initiation and modulation of allergic reactions while also exerting regulatory functions that can down regulate inflammation.
The overarching goal of RTG 3095 is to elucidate the mechanisms by which B cell responses are initiated maintained and contribute to either immunoprotection or immunopathogenesis at these immunological barrier sites. To achieve this the programme employs state-of-the-art experimental approaches including single-cell sequencing spatial transcriptomics and advanced molecular and immunological techniques. Doctoral researchers will benefit from a structured 4-year training programme that integrates cutting-edge research with comprehensive training opportunities.
Start in our team
Within this framework the subproject P06 Lung-resident B cells as producers of Immunoglobulin A led by Prof. Andreas Hutloff at the Institute for Immunology Kiel University is seeking a PhD Candidate to start on April 1 2026. The position is initially limited until March 31 2030.
What we offer you:
What you can expect:
Your profile:
Application:
Please include the following documents with your application:
Selection process
Application to this subproject of RTG 3095 is generally considered to be an application also to the other subprojects of RTG 3095. Separate application to another subproject is not required but please indicate in your motivation letter your favoured RTG3095 subprojects (see above motivation letter).
Among the written applications the most suitable candidates will be invited to a one-day symposium which will take place in January 2026 in Lübeck Germany.
We look forward to receiving your application by 14.12.2025 quoting reference number 27559.
Contact
Prof. Andreas Hutloff Institute for Immunology Kiel University